Skip to main content
Clinical Trials/CTRI/2019/06/019580
CTRI/2019/06/019580Completed未知

Efficacy of Khadiradi Ghanvati and Chankraman in the Management of Madhumeha (Type 2 Diabetes)- An Open Randomized Comparative Clinical Trial

Director IPGT and RA GAU Jamnagar0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients of both male and female sexes from
  • age group 20-60 years.
  • 2. Signs and symptoms of Madhumeha.
  • 3. Fasting Blood Plasma glucose. >=7.0mmol/l
  • (126mg/dl) OR Post Prandial Blood Plasma
  • Glucose >=11.1mmol/l (200mg/dl).
  • 4. BMI >= 23 Kg/m2 to 30 Kg/m2
  • 5. Diagnosed cases who are not practicing 6 km
  • regular walk

Exclusion Criteria

  • 1. Patients of Diabetes mellitus receiving
  • 2. Patients having chronic complications of
  • Diabetes mellitus.
  • 3. Micro vascular Retinopathy, Neuropathy and
  • Nephropathy Macro vascular Coronary artery
  • disease, Peripheral vascular disease &
  • Cerebro-vascular disease.
  • 4. Other chronic debilitating disease like STD
  • 5. Pregnant and lactating women.
  • 6. Tuberculosis and HIV.
  • 7. Patients with Prameha Pidika (carbuncle,
  • furuncles, abscess)

Investigators

Sponsor
Director IPGT and RA GAU Jamnagar

Similar Trials